Top 10 North American Pharma-Biotech Capital Projects for 2007 Deliver $4.1 Billion Investment
Top 10 North American Pharma-Biotech Capital Projects for 2007 Deliver $4.1 Billion Investment
Attachment: Top 10 North Pharma-Biotech Industry Projects for 2007 Chart
The 2007 figures virtually mirror 2006, with just a negligible increase. The 2006 total TIV was $4.14 billion, which resulted in an average project TIV of $414 million.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
